GB1552708A - Process for producing intravenous immune globulin - Google Patents

Process for producing intravenous immune globulin

Info

Publication number
GB1552708A
GB1552708A GB49256/77A GB4925677A GB1552708A GB 1552708 A GB1552708 A GB 1552708A GB 49256/77 A GB49256/77 A GB 49256/77A GB 4925677 A GB4925677 A GB 4925677A GB 1552708 A GB1552708 A GB 1552708A
Authority
GB
United Kingdom
Prior art keywords
immune globulin
intravenous immune
producing
producing intravenous
globulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB49256/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parke Davis and Co LLC
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Publication of GB1552708A publication Critical patent/GB1552708A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
GB49256/77A 1976-11-26 1977-11-25 Process for producing intravenous immune globulin Expired GB1552708A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/744,906 US4075193A (en) 1976-11-26 1976-11-26 Process for producing intravenous immune globulin

Publications (1)

Publication Number Publication Date
GB1552708A true GB1552708A (en) 1979-09-19

Family

ID=24994418

Family Applications (1)

Application Number Title Priority Date Filing Date
GB49256/77A Expired GB1552708A (en) 1976-11-26 1977-11-25 Process for producing intravenous immune globulin

Country Status (7)

Country Link
US (1) US4075193A (enExample)
JP (1) JPS5369823A (enExample)
CA (1) CA1083959A (enExample)
DE (1) DE2752694A1 (enExample)
FR (1) FR2372173B1 (enExample)
GB (1) GB1552708A (enExample)
NL (1) NL7713023A (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
DE2658334C3 (de) * 1976-12-23 1987-05-07 Behringwerke Ag, 3550 Marburg Verfahren zum Herstellen von Immunglobulinpräparationen mit verminderter Komplementaktivität und ein diese enthaltendes Arzneimittel
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
DE2846412A1 (de) * 1978-10-25 1980-05-08 Behringwerke Ag Mittel zur behandlung allergischer reaktionen
JPS55124719A (en) * 1979-03-22 1980-09-26 Kowa Co Preparation of immune globulin administrable by intravenous injection
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
DE2933015A1 (de) * 1979-08-16 1981-03-26 Behringwerke AG, 35041 Marburg Verfahren zur herstellung der dritten komponente des komplements aus menschlichem blutplasma
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
US5211850A (en) * 1991-07-26 1993-05-18 Research Medical, Inc. Plasma filter sorbent system for removal of components from blood
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
EP0835880A1 (de) * 1996-10-14 1998-04-15 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
ATE442862T2 (de) * 2000-10-12 2009-10-15 Genentech Inc Niederviskose konzentrierte proteinformulierungen
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US20100184132A1 (en) * 2006-01-13 2010-07-22 Secretary, Department Of Atomic Energy Enzymatic Process for Debittering of Protein Hydrolysate Using Immobilized Peptidases
US20110123819A1 (en) * 2007-12-21 2011-05-26 Ge Healthcare Bio-Sciences Ab Method for sterilization of chemically activated solid support materials
AR076640A1 (es) * 2009-03-06 2011-06-29 Genentech Inc Formulacion con anticuerpo. metodo para estabilizar anticuerpo. articulo de manufactura
CA2976671C (en) 2010-03-01 2021-01-12 Bayer Healthcare Llc Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
US9592297B2 (en) 2012-08-31 2017-03-14 Bayer Healthcare Llc Antibody and protein formulations
US8613919B1 (en) 2012-08-31 2013-12-24 Bayer Healthcare, Llc High concentration antibody and protein formulations
US20180305401A1 (en) * 2015-10-21 2018-10-25 Cambryn Biologics, Llc Processes for purifying proteins from plasma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966906A (en) * 1961-10-11 1976-06-29 Behringwerke Aktiengesellschaft Disaggregated gamma globulin and process for preparing it
US3449316A (en) * 1967-03-03 1969-06-10 American Cyanamid Co Process for the purification of gamma globulin employing bentonite
US3808124A (en) * 1972-04-14 1974-04-30 American Cyanamid Co Purification of human plasminogen
US3943245A (en) * 1974-02-14 1976-03-09 Armour Pharmaceutical Company Purification of plasminogen

Also Published As

Publication number Publication date
JPS5369823A (en) 1978-06-21
NL7713023A (nl) 1978-05-30
US4075193A (en) 1978-02-21
CA1083959A (en) 1980-08-19
FR2372173A1 (enExample) 1978-06-23
DE2752694A1 (de) 1978-06-01
FR2372173B1 (enExample) 1981-01-09

Similar Documents

Publication Publication Date Title
GB1552708A (en) Process for producing intravenous immune globulin
JPS52136300A (en) Process for producing crossslinked plastics
YU190277A (en) Process for producing methacrolein
JPS5329399A (en) Process for producing polyetherrpolyol
HU177073B (en) Process for producing cyrally substituted 2-imidasolin-5-ones
YU98777A (en) Process for producing antibiotical agentes
HU174836B (hu) Sposob poluchenija meta-fenoksi-benzaldegida
SU913943A3 (en) Process for producing cephalosporins
JPS538699A (en) Process for producing nonnfoammlike object
HU175013B (hu) Sposob poluchenija kompozicii korma
JPS5358593A (en) Process for producing low molecularrweight polyyanhydrides
HU175456B (hu) Sposob poluchenija s-triazinov
JPS5366991A (en) Process for producing composite
HU172938B (hu) Sposob poluchenija zamehhennykh fenilacetilenov
JPS51127191A (en) Process for producing synthetic resin
HU175361B (hu) Sposob poluchenija novykh 1-sul'fonil-5-skobka-6-skobka zakryta-zamehhennykh-benzimidazolov
YU161282A (en) Process for producing azol-amides
JPS5323391A (en) Process for producing sbrrrubber
HU179561B (en) Process for producing neoviridogrisein-antibiotics
YU173883A (en) Process for producing 1-oxadethiacephalosporins
HU178334B (en) Process for producing prostaglandine a2
JPS5214696A (en) Process for producing flameeretardant polytriazine
JPS537794A (en) Process for producing impacttresistant polysyrene
JPS52105980A (en) Process for producing cushionnlike object
HU175190B (hu) Sposob poluchenija inozina

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee